Between the Bells
Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge.
Find Bell Direct here:
Website: https://www.belldirect.com.au/smarter/
Twitter: https://twitter.com/belldirect
Facebook: https://www.facebook.com/BellDirectAustralia
LinkedIn: https://www.linkedin.com/company/bell-direct/
Instagram: https://www.instagram.com/bell.direct/
Podcasting since 2020 • 1675 episodes
Between the Bells
Latest Episodes
From the helm: Summerset Group Holdings (ASX:SNZ), CFO, Margaret Warrington.
In this episode of From the Helm, Grady sits down with Summerset Group Holdings (ASX:SNZ) CFO Margaret Warrington to unpack their end-to-end business model for aged care sites, from land acquisition all the way through to building and operating...
•
10:57
From the helm: Amplia Therapeutics (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pan...
•
13:49
From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.
In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive diseas...
•
11:10
From the helm: Neuren Pharmaceuticals (ASX:NEU), CEO, Jon Pilcher.
In this episode of From the Helm, Grady sits down with Neuren Pharmaceuticals (ASX:NEU) CEO Jon Pilcher, to recap on their major developments over the last 12 months in the US market, their guidance looking ahead for next financial year, and th...
•
15:25
From the helm: Saluda Medical (ASX:SLD), President & CEO, Barry Regan
In this episode of From the Helm, Grady chats with Saluda Medical (ASX:SM1) President and CEO Barry Regan to discuss their recent developments since their IPO in November, their developmental drug for the treatment of chronic pain, and what is ...
•
17:10